Cargando…

Broad Protection of Pigs against Heterologous PRRSV Strains by a GP5-Mosaic DNA Vaccine Prime/GP5-Mosaic rVaccinia (VACV) Vaccine Boost

Background: Porcine reproductive and respiratory syndrome (PRRS) viruses are a major cause of disease and economic loss in pigs worldwide. High genetic diversity among PRRSV strains is problematic for successful disease control by vaccination. Mosaic DNA and vaccinia (VACV) vaccines were developed i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Junru, O’Connell, Caitlin M., Hagen, Connor, Sawicki, Kim, Smyth, Joan A., Verardi, Paulo H., Van Kruiningen, Herbert J., Garmendia, Antonio E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157218/ https://www.ncbi.nlm.nih.gov/pubmed/32121277 http://dx.doi.org/10.3390/vaccines8010106

Ejemplares similares

A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNγ responses against several genotype 2 strains
por: Cui, Junru, et al.
Publicado: (2019)

Correction: A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNγ responses against several genotype 2 strains
por: Cui, Junru, et al.
Publicado: (2019)

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo
por: Zhao, Guanyu, et al.
Publicado: (2022)

Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge
por: Clark, Kimberly M., et al.
Publicado: (2011)

Genetic variation and recombination analysis of the GP5 (GP5a) gene of PRRSV-2 strains in China from 1996 to 2022
por: Luo, Qin, et al.
Publicado: (2023)

A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques
por: Florek, Kelsey R., et al.
Publicado: (2017)

Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells
por: Kilinc, Mehmet Okyay, et al.
Publicado: (2016)

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
por: Shen, Xiaoying, et al.
Publicado: (2017)

Targeted Delivery of GP5 Antigen of PRRSV to M Cells Enhances the Antigen-Specific Systemic and Mucosal Immune Responses
por: Du, Luping, et al.
Publicado: (2018)

MYH9 Aggregation Induced by Direct Interaction With PRRSV GP5 Ectodomain Facilitates Viral Internalization by Permissive Cells
por: Xue, Biyun, et al.
Publicado: (2019)

Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV)
por: Zheng, Qisheng, et al.
Publicado: (2007)

One More Piece in the VACV Ecological Puzzle: Could Peridomestic Rodents Be the Link between Wildlife and Bovine Vaccinia Outbreaks in Brazil?
por: Abrahão, Jônatas S., et al.
Publicado: (2009)

Construction and immunogenicity of a DNA vaccine coexpressing GP3 and GP5 of genotype-I porcine reproductive and respiratory syndrome virus
por: Ren, Jing-Qiang, et al.
Publicado: (2014)

A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice
por: Suschak, John J., et al.
Publicado: (2021)

Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses
por: Perdiguero, Beatriz, et al.
Publicado: (2019)

Stability and neutralization capacity of a novel mosaic HIV-1 gp140 trimer in a guinea pig model
por: Nkolola, JP, et al.
Publicado: (2012)

Langerin+ Dermal DC, but not Langerhans cells, are required for effective CD8 mediated immune responses after skin scarification with Vaccinia Virus (VACV)
por: Seneschal, Julien, et al.
Publicado: (2013)

Construction and immunological evaluation of recombinant adenovirus vaccines co-expressing GP3 and GP5 of EU-type porcine reproductive and respiratory syndrome virus in pigs
por: XIE, Changzhan, et al.
Publicado: (2019)

THE MEASUREMENT OF SURFACE FILMS FORMED BY HEMOCYANIN, TOBACCO MOSAIC VIRUS, VACCINIA, AND BACTERIUM GALLINARUM
por: Seastone, C. V.
Publicado: (1938)

Comparative evaluation of 4 commercial modified‐live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous dual Korean PRRSV‐1 and PRRSV‐2 challenge
por: Oh, Taehwan, et al.
Publicado: (2020)

Phenotypic Characterization of a Virulent PRRSV-1 Isolate in a Reproductive Model With and Without Prior Heterologous Modified Live PRRSV-1 Vaccination
por: Kreutzmann, Heinrich, et al.
Publicado: (2022)

Signal Peptide Cleavage from GP5 of PRRSV: A Minor Fraction of Molecules Retains the Decoy Epitope, a Presumed Molecular Cause for Viral Persistence
por: Thaa, Bastian, et al.
Publicado: (2013)

Expression of the Heterotrimeric GP2/GP3/GP4 Spike of an Arterivirus in Mammalian Cells
por: Matczuk, Anna Karolina, et al.
Publicado: (2022)

Mosaics
por: Hetherington, P. B.
Publicado: (1967)

Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice
por: Chapman, Ros, et al.
Publicado: (2017)

OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
por: Strbo, N, et al.
Publicado: (2009)

Germline mosaicism in a family with MBD5 haploinsufficiency
por: Bhatia, Mehak, et al.
Publicado: (2022)

Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets
por: Papakonstantinou, Georgios, et al.
Publicado: (2022)

A vaccinia virus renaissance: New vaccine and immunotherapeutic uses after smallpox eradication
por: Verardi, Paulo H., et al.
Publicado: (2012)

Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model
por: Page, Mark, et al.
Publicado: (2012)

Differential host cell gene expression regulated by the porcine reproductive and respiratory syndrome virus GP4 and GP5 glycoproteins
por: Lee, Changhee, et al.
Publicado: (2004)

Preimplantation chromosomal mosaics, chimaeras and confined placental mosaicism
por: West, John D, et al.
Publicado: (2022)

A gp63 based vaccine candidate against Visceral Leishmaniasis
por: Sinha, Sukrat, et al.
Publicado: (2011)

Placenta-derived gp96 as a multivalent prophylactic cancer vaccine
por: Zhao, Bao, et al.
Publicado: (2013)

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
por: Agnolon, Valentina, et al.
Publicado: (2020)

The Host E3-Ubiquitin Ligase TRIM28 Impedes Viral Protein GP4 Ubiquitination and Promotes PRRSV Replication
por: Cui, Zhiying, et al.
Publicado: (2023)

Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges
por: Geldhof, Marc F, et al.
Publicado: (2012)

Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus
por: Evans, Mark F, et al.
Publicado: (2005)

Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding
por: Illick, Megan M, et al.
Publicado: (2008)

Folding and Oligomerization of the gp2b/gp3/gp4 Spike Proteins of Equine Arteritis Virus in Vitro
por: Kabatek, Aleksander, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ctcmvkl1ra9v6s2urgqn6m537d